Skip to content

Insider · CIK 0001617306

Marc J Yoskowitz

director

Files at MNKTQ (Mallinckrodt plc), MREO (Mereo BioPharma Group plc). First filing -, latest -.

In brief

Marc J Yoskowitz files SEC Form 4 as director at MNKTQ (Mallinckrodt plc), and also at MREO (Mereo BioPharma Group plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Marc J Yoskowitz has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 10 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 15, 2026MNKTQ
Mallinckrodt plc
AGrant or award
Restricted Stock Unitsderivative
+4,406$0.00$09,718Jul 17, 2026
Jun 2, 2026MNKTQ
Mallinckrodt plc
MOption exercise
Ordinary Shares
+3,579--4,366Jun 4, 2026
Jun 2, 2026MNKTQ
Mallinckrodt plc
FTax withholding
Ordinary Shares
-825--3,541Jun 4, 2026
Jun 2, 2026MNKTQ
Mallinckrodt plc
DDisposition to issuer
Restricted Stock Unitsderivative
-2,930--8,891Jun 4, 2026
Jun 2, 2026MNKTQ
Mallinckrodt plc
MOption exercise
Restricted Stock Unitsderivative
-3,579$0.00$05,312Jun 4, 2026
Feb 26, 2026MREO
Mereo BioPharma Group plc
AGrant or award
Share Options (Right to buy)derivative
+66,000$0.00$066,000Feb 27, 2026
Feb 26, 2026MREO
Mereo BioPharma Group plc
AGrant or award
Deferred Restricted Stock Unitsderivative
+96,163--96,163Feb 27, 2026
Feb 23, 2026MNKTQ
Mallinckrodt plc
AGrant or award
Restricted Stock Unitsderivative
+5,312$0.00$011,821Feb 25, 2026
Oct 20, 2025MNKTQ
Mallinckrodt plc
AGrant or award
Restricted Stock Unitsderivative
+1,354$0.00$05,416Oct 20, 2025
Aug 14, 2025MNKTQ
Mallinckrodt plc
AGrant or award
Restricted Stock Unitsderivative
+4,062$0.00$04,062Aug 18, 2025

Questions about Marc J Yoskowitz

Answered from the filings on this page, as of the latest one.

Is Marc J Yoskowitz buying or selling?

Marc J Yoskowitz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Marc J Yoskowitz's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marc J Yoskowitz has 0.

Where does Marc J Yoskowitz file Form 4?

Marc J Yoskowitz has filed Form 4 at MNKTQ (Mallinckrodt plc); MREO (Mereo BioPharma Group plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Marc J Yoskowitz: insider trades and track record | InsiderTell